Hofer Debora M, Ruzzante Livio, Waskowski Jan, Messmer Anna S, Pfortmueller Carmen A
Department of Intensive Care Medicine, Inselspital, Bern University Hospital, Freiburgstrasse 18, Bern, CH-3010, Switzerland.
Ann Intensive Care. 2024 Apr 8;14(1):52. doi: 10.1186/s13613-024-01281-7.
Fluid accumulation (FA) is known to be associated with acute kidney injury (AKI) during intensive care unit (ICU) stay but data on mid-term renal outcome is scarce. The aim of this study was to investigate the association between FA at ICU day 3 and major adverse kidney events in the first 30 days after ICU admission (MAKE30).
Retrospective, single-center cohort study including adult ICU patients with sufficient data to compute FA and MAKE30. We defined FA as a positive cumulative fluid balance greater than 5% of bodyweight. The association between FA and MAKE30, including its sub-components, as well as the serum creatinine trajectories during ICU stay were examined. In addition, we performed a sensitivity analysis for the stage of AKI and the presence of chronic kidney disease (CKD).
Out of 13,326 included patients, 1,100 (8.3%) met the FA definition. FA at ICU day 3 was significantly associated with MAKE30 (adjusted odds ratio [aOR] 1.96; 95% confidence interval [CI] 1.67-2.30; p < 0.001) and all sub-components: need for renal replacement therapy (aOR 3.83; 95%CI 3.02-4.84), persistent renal dysfunction (aOR 1.72; 95%CI 1.40-2.12), and 30-day mortality (aOR 1.70; 95%CI 1.38-2.09), p all < 0.001. The sensitivity analysis showed an association of FA with MAKE30 independent from a pre-existing CKD, but exclusively in patients with AKI stage 3. Furthermore, FA was independently associated with the creatinine trajectory over the whole observation period.
Fluid accumulation is significantly associated with MAKE30 in critically ill patients. This association is independent from pre-existing CKD and strongest in patients with AKI stage 3.
已知在重症监护病房(ICU)住院期间,液体潴留(FA)与急性肾损伤(AKI)相关,但关于中期肾脏转归的数据较少。本研究的目的是调查ICU第3天的FA与ICU入院后前30天内主要不良肾脏事件(MAKE30)之间的关联。
一项回顾性单中心队列研究,纳入有足够数据计算FA和MAKE30的成年ICU患者。我们将FA定义为正性累积液体平衡大于体重的5%。研究了FA与MAKE30及其子成分之间的关联,以及ICU住院期间的血清肌酐轨迹。此外,我们对AKI分期和慢性肾脏病(CKD)的存在进行了敏感性分析。
在纳入的13326例患者中,1100例(8.3%)符合FA定义。ICU第3天的FA与MAKE30显著相关(校正比值比[aOR]1.96;95%置信区间[CI]1.67 - 2.30;p < 0.001)及其所有子成分:肾脏替代治疗需求(aOR 3.83;95%CI 3.02 - 4.84)、持续性肾功能不全(aOR 1.72;95%CI 1.40 - 2.12)和30天死亡率(aOR 1.70;95%CI 1.38 - 2.09),p均< 0.001。敏感性分析显示,FA与MAKE30的关联独立于既往存在的CKD,但仅在AKI 3期患者中存在。此外,在整个观察期内,FA与肌酐轨迹独立相关。
在危重症患者中,液体潴留与MAKE30显著相关。这种关联独立于既往存在的CKD,且在AKI 3期患者中最强。